Health-related quality of life and health utility among patients with diabetes in Zabol, Southeast Iran

被引:0
作者
Hedayati, Seyed Pouria [1 ]
Haghparast-Bidgoli, Hassan [2 ]
Kiadaliri, Aliasghar A. [3 ]
Mohabati, Fatemeh [1 ]
机构
[1] Univ Tehran Med Sci, Dept Hlth Management & Econ, Sch Publ Hlth, Tehran, Iran
[2] UCL, Inst Global Hlth, London, England
[3] Lund Univ, Fac Med, Dept Clin Sci Lund, Orthopaed,Clin Epidemiol Unit, Lund, Sweden
来源
JOURNAL OF CONTEMPORARY MEDICAL SCIENCES | 2020年 / 6卷 / 02期
关键词
Diabetes; Health-related quality of life; Health utility; EQ-5D-3L; Iran; EQ-5D; POPULATION; RISK; EUROQOL; COMPLICATIONS; MELLITUS; GLUCOSE; VALUES; PREVALENCE; MORTALITY;
D O I
10.22317/jcms.v6i2.727
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The current study aimed to assess the factors associated with health-related quality of life (HRQoL) and health utility (HU) among patients with diabetes in Zabol, Southeast Iran. Methods Among patients referred to Zabol city diabetes clinic, a total of 213 consecutive patients 18 years and older consent to participate in the study in 2015. The Persian version of EuroQol-5D-3L (EQ-5D-3L) using the UK preference weights was applied to derive HU. Logistic regression and ordinary least squares were used for data analysis. The STATA version 13 (StataCorp LP, College Station, TX, USA) was used for statistical analysis. Results The highest and lowest proportions of "some or extreme problems" were seen in pain/discomfort (86.6%) and self-care (27.8%) dimensions of the EQ-5D-3L, respectively. About 33% of women and 14% of men rated their health worse than death (p=0.002). The mean EQ-5D-3L index score and visual analogue scale were 0.37 (95% CI: 0.31-0.42) and 51.6 (95% CI: 48.7-54.5), respectively. Older age at diagnosis, longer duration of diabetes, lower education, and history of macrovascular complications were associated with lower HRQoL and HU. Conclusion This study highlights the importance of education and diabetes-related complications in HRQoL/HU of diabetes people. The findings suggest that urgent interventions are required to improve HRQoL/HU of diabetes patients in Zabol. Moreover, our results provide inputs for future economic evaluation studies among diabetes patients with similar socioeconomic status in Iran.
引用
收藏
页码:59 / 65
页数:7
相关论文
共 47 条
  • [1] A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states
    Badia, X
    Roset, M
    Herdman, M
    Kind, P
    [J]. MEDICAL DECISION MAKING, 2001, 21 (01) : 7 - 16
  • [2] Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data
    Bagust, A
    Beale, S
    [J]. HEALTH ECONOMICS, 2005, 14 (03) : 217 - 230
  • [3] Review of Utility Values for Economic Modeling in Type 2 Diabetes
    Beaudet, Amelie
    Clegg, John
    Thuresson, Per-Olof
    Lloyd, Adam
    McEwan, Phil
    [J]. VALUE IN HEALTH, 2014, 17 (04) : 462 - 470
  • [4] The estimation of a preference-based measure of health from the SF-36
    Brazier, J
    Roberts, J
    Deverill, M
    [J]. JOURNAL OF HEALTH ECONOMICS, 2002, 21 (02) : 271 - 292
  • [5] Brazier J, 1999, J Health Serv Res Policy, V4, P174
  • [6] EuroQol: The current state of play
    Brooks, R
    [J]. HEALTH POLICY, 1996, 37 (01) : 53 - 72
  • [7] Estimating the SF-6D Value Set for a Population-Based Sample of Brazilians
    Cruz, Luciane N.
    Camey, Suzi A.
    Hoffmann, Juliana F.
    Rowen, Donna
    Brazier, John E.
    Fleck, Marcelo P.
    Polanczyk, Carisi A.
    [J]. VALUE IN HEALTH, 2011, 14 (05) : S108 - S114
  • [8] Dolan P, 1996, HEALTH ECON, V5, P141, DOI 10.1002/(SICI)1099-1050(199603)5:2<141::AID-HEC189>3.0.CO
  • [9] 2-N
  • [10] Prevalence of diabetes and impaired fasting glucose in the adult population of Iran - National Survey of Risk Factors for Non-Communicable Diseases of Iran
    Esteghamati, Alireza
    Gouya, Mohamad M.
    Abbasi, Mehrshad
    Delavari, Alireza
    Alikhani, Siamak
    Alaedini, Farishid
    Safaie, Afshin
    Forouzanfar, Mehrdad
    Gregg, Edward W.
    [J]. DIABETES CARE, 2008, 31 (01) : 96 - 98